Overview
- 9 inspections across 9 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2014-06-27.
At a glance
Inspections
9
Sites
9
Observations
0
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| CSL Behring L.L.C. | 27 Jun 2014 | Biologics | On file |
| Catalent Indiana, LLC | 24 Feb 2012 | On file | |
| Kedrion S.p.A. | 2 Mar 2011 | On file | |
| Grifols Therapeutics LLC | 14 May 2010 | On file | |
| GlaxoSmithKline Biologicals Kft. | 12 Mar 2010 | On file |
Sites inspected
CSL Behring L.L.C.Bradley, United States1 insp.
Catalent Indiana, LLCBloomington, United States1 insp.
Kedrion S.p.A.Gallicano, Italy1 insp.
Grifols Therapeutics LLCClayton, United States1 insp.
GlaxoSmithKline Biologicals Kft.Godollo, Hungary1 insp.
Co-investigators
Investigators who share inspections with this person.
Richard H Coats1 shared
Rabia Ballica1 shared
Robert M Barbosa1 shared
Lori P Peters1 shared
Joseph George1 shared
Donald B Ertel1 shared
Nawab A Siddiqui1 shared
Zhihao Pete Qiu1 shared
Joseph D Doleski1 shared
Prabhu P Raju1 shared
Full investigator report
Get the verbatim findings behind Sean R Byrd's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site